GCA belongs to the field of autoimmune and rheumatic immunity. The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardization of the diagnosis is essential for improving the prognosis.
Diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological checks. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of GCA needs to be individualized, usually including multidimensional management, such as drug therapy, rehabilitation, regular follow-up.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many autoimmune and rheumatoid immunodeficiency disorders that were previously difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to changes in the condition. Multidisciplinary collaboration (MDT) is especially important for the integrated management of GCA.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.